PharmaBoardroom’s latest report, InFigures: Asia Pacific 2023 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings, innovation footprints, IPOs,…
Currently in the midst of a generational transformation of its healthcare system, Egypt has more to recommend it than ever to the global life sciences investment community. Not only is the country attempting to bring its entire 100+ million population under some form of…
With the tremendous healthcare momentum that is already underway in the Gulf Cooperation Council (GCC) countries, driven by economic diversification and transformation, the future of healthcare in the region looks bright. Government initiatives such as Saudi Arabia’s…
At a crucial moment ahead of a snap general election on 25 September 2022, this new report looks back at the progress that Italy’s healthcare and life sciences sector has made in recent years and assesses its future prospects. While the country’s political winds are…
Having foregrounded its life sciences credentials with the establishment of manufacturing and clinical trials hubs, Spain is hoping to secure its position as a globally relevant industry player. The Iberian nation can boast an advanced healthcare system – which has…
PharmaBoardroom’s latest report, InFigures: Middle East & Africa (MENA) 2022 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. MENA may be the smallest pharmaceutical market in the world, accounting for just 2 percent…
PharmaBoardroom’s latest report, InFigures: European Pharma Hotspots 2022 features up-to-date datasets from six major European pharma hubs. Europe is the world’s second biggest pharma market region and boasts the headquarters of some of the world’s largest pharma…
PharmaBoardroom’s latest report, InFigures: Latin America 2022 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. A regional market of USD 98 billion looks set to be the fastest growing in the world over the next few…
Saudi Arabia – by many measures the cultural, social, and economic centre of the Arab and Islamic worlds – is currently undergoing a once-in-a-lifetime transformation. The ‘Vision 2030’ transformation plan is not only reshaping the Saudi economy and reducing its…
Despite its diminutive size, Denmark boasts a world-renowned healthcare and life science industry containing both household pharma giants as well as a robust network of academia, a host of niche service providers, and a growing throng of biotech start-ups. With life…
On the verge of its 100th anniversary, the Republic of Turkey appears to be approaching a decisive moment in the trajectory of its healthcare industry. With a comprehensive social security system covering over 95 percent of the population already in the bag, and after more…
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2021 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings, innovation footprints, IPOs,…